The Endocrine Society Education & Events

ENDO 2006
ENDO 2006: Abstract Submissions
Abstract Submissions - ENDO 2006
Regional Dinner Program Series
The Endocannabinoid System: A New Target for the Reduction of Cardiovascular Risk Factors
Explore the cannabinoid receptor 1 antagonists, a novel class of therapeutics that is under clinical investigation for efficacy and safety in weight loss and weight management.
Power Point Slides
A. Obesity & CVD Part 1
A. Obesity & CVD Part 1
B. Obesity & CVD Part 2
B. Obesity & CVD Part 2
C. Obesity & CVD Part 3
C. Obesity & CVD Part 3
D. The ECS & Obesity - Part 1
D. The ECS & Obesity - Part 1
E. The ECS & Obesity - Part 2
E. The ECS & Obesity - Part 2
F. The ECS & Obesity - Part 3
F. The ECS & Obesity - Part 3
G. The ECS & Obesity - Part 4
G. The ECS & Obesity - Part 4
Educational Resources
There are no additional educational resources for this subject.
Other Educational Events
Print This Page Email This Page

Related Info

The Endocrine Society Weighs In: A Handbook on Obesity in Obesity in America
Awareness Campaign: Obesity in America